We are monitoring the impact of COVID-19 & Recession alarm on MEA Capecitabine Market Get in touch with us for detailed analysis Know More

Know More

Share on

Middle East & Africa Capecitabine Market Research Report - Segmented By Application, Drug Formulation & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 6201
Pages: 145

MEA Capecitabine Market Size & Growth (2022 to 2027):

As per the research report, the size of the Middle East and Africa Capecitabine market was valued at USD XX Million in 2022 and is expected to reach USD XX Million by 2027 at XX% CAGR during the forecast period 2022 to 2027. 

The Middle East and Africa capecitabine market is expected to grow in response to the growing demand for target medications that reduce potential side effects while preserving healthy cells.

Due to the increased demand for target medication therapy to reduce probable side effects without impacting normal cells, the Capecitabine market is expected to rise steadily throughout the forecast period. The increased demand for capecitabine can be ascribed to its antimetabolite action, which operates by interfering with DNA synthesis and reducing the severity of side effects. In addition, the industry is also projected to be driven by the rising number of people diagnosed with cancer and tumors. 

According to the WHO, cancer is the most significant cause of death worldwide, with approximately 9.6 million deaths projected in 2018. Furthermore, breast cancer claimed the lives of 627,000 women worldwide, accounting for nearly 15% of all cancer fatalities among women.

In addition, a sharp increase in healthcare spending and continued R&D initiatives in cancer therapy are likely to open up new market prospects. Furthermore, increased awareness campaigns by governments and private organizations are expected to drive capecitabine market growth in the Middle East and Africa throughout the forecast period. However, Capecitabine's market in the Middle East and Africa is limited by its high cost and tight safety and efficacy standards.

A drug can produce adverse side effects as well as its intended effects. In some cases, seeking medical attention may be necessary even if they are no adverse effects. Symptoms include stomach aches, diarrhea, fingerprint loss, nausea, numbness, discomfort, tingling, skin changes, blisters, peeling, redness, swelling in the fingers and toes, and blistering the skin.

These factors are expected to restrain the Middle East and Africa Capecitabine market during the forecast period.

This research report on the MEA Capecitabine Market has been segmented and sub-segmented into the following categories:

By Application:

  • Colon Cancer
  • Rectal Cancer
  • Breast Cancer
  • Gastric Cancer
  • Others

By Drug Formulation:

  • Tablets
  • Capsules

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, Capecitabine is a moderately competitive market with several leading companies in the Middle East and Africa. A few of the market's most potent firms employ various techniques to consolidate their market positions across the continent, such as acquiring items or other companies and others releasing generic products. 

The market is likely to grow due to the increased prevalence of colorectal cancer and colon cancer in the region throughout the forecast period. Physical inactivity, obesity, stress, and a sedentary lifestyle are all factors that can contribute to rising cancer rates. Furthermore, the presence of baby boomers in this region during the predicted period results in a sharp increase in the old population, resulting in increased revenue.

The Saudi Arabia Capecitabine market is expected to dominate the Middle East and Africa region during the projection period. The market is fueled by a large target population and growing disposable income in the area. Furthermore, the presence of prominent players is projected to contribute to the Middle East and Africa Capecitabine market's large revenue share.

South Africa Capecitabine market is predicted to hold the largest share of the Middle East and Africa Capecitabine market, following Saudi Arabia. Prescriptions for the medicine as the gold standard have increased due to its established efficacy in the treatment of breast cancer. One of the elements propelling the market in this region is this.


The leading companies leading in the MEA Capecitabine Market profiled in the report are Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.,

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods     

                1.4 General Study Assumptions      

2. Research Methodology                               

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Application                                                 

                                5.1.1 Introduction                                           

                                5.1.2 Colon Cancer                                          

                                5.1.3 Rectal Cancer                                         

                                5.1.4 Breast Cancer                                        

                                5.1.5 Gastric Cancer                                       

                                5.1.6 Others                                      

                                5.1.7 Y-o-Y Growth Analysis, By Application                                         

                                5.1.8 Market Attractiveness Analysis, By Application                                       

                                5.1.9 Market Share Analysis, By Application                                        

                5.2 Drug Formulation                                                     

                                5.2.1 Introduction                                           

                                5.2.2 Tablets                                      

                                5.2.3 Capsules                                  

                                5.2.4 Y-o-Y Growth Analysis, By Drug Formulation                                            

                                5.2.5 Market Attractiveness Analysis, By Drug Formulation                                          

                                5.2.6 Market Share Analysis, By Drug Formulation                                            

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                       By Geographical Area                     

                                       By Application                    

                                       By Drug Formulation                       

                                6.1.4  Market Attractiveness Analysis                                     

                                       By Geographical Area                     

                                       By Application                    

                                       By Drug Formulation                       

                                6.1.5  Market Share Analysis                                      

                                       By Geographical Area                     

                                       By Application                    

                                       By Drug Formulation                       

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Novartis AG                                                

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Sensus Healthcare                                                   

                8.3 RXi Pharmaceuticals Inc.                                                       

                8.4 Sonoma Pharmaceuticals Inc.                                                             

                8.5 Perrigo Company plc                                                              

                8.6 Bristol-Myers Squibb Company                                                         

                8.7 Pacific World Corporation                                                     

                8.8 Valeant Pharmaceuticals International Inc.                                                   

                8.9 Revitol Corporation                                                 

                8.10 Avita Medical Limited.                                                         

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         


                a) List of Tables                                                

                b) List of Figures                                                              

  1. Middle East and Africa Capecitabine  Market By Application, From 2022 - 2027 ( USD Million )
  2. Middle East and Africa Colon Cancer Market By Region, From 2022 - 2027 ( USD Million )
  3. Middle East and Africa Rectal Cancer Market By Region, From 2022 - 2027 ( USD Million )
  4. Middle East and Africa Breast Cancer Market By Region, From 2022 - 2027 ( USD Million )
  5. Middle East and Africa Gastric Cancer Market By Region, From 2022 - 2027 ( USD Million )
  6. Middle East and Africa Others Market By Region, From 2022 - 2027 ( USD Million )
  7. Middle East and Africa Capecitabine  Market By Drug Formulation, From 2022 - 2027 ( USD Million )
  8. Middle East and Africa Tablets Market By Region, From 2022 - 2027 ( USD Million )
  9. Middle East and Africa Capsules Market By Region, From 2022 - 2027 ( USD Million )
  10. Middle East Capecitabine  Market By Application, From 2022 - 2027 ( USD Million )
  11. Middle East Capecitabine  Market By Drug Formulation, From 2022 - 2027 ( USD Million )
  12. Africa Capecitabine  Market By Application, From 2022 - 2027 ( USD Million )
  13. Africa Capecitabine  Market By Drug Formulation, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample